Sam Patrick posted an articleHITACHI TO EXPAND ITS CLINICAL REPORTING AND ANALYTICS FOR DIAGNOSTIC IMAGING WITH THE ACQUISITION OF VIDISTARHitachi Healthcare Americas Corp. has entered an agreement to acquire Greenville, SC's VidiStar, LLC see more
Twinsburg, OH January 9, 2018 - Hitachi Healthcare Americas Corporation, a wholly owned subsidiary of Hitachi, Ltd. (TSE: 6501) and a leading provider of medical imaging modalities to hospital and ambulatory clients nationwide, today announced that it has entered into an agreement to acquire VidiStar, LLC, a Greenville, SC-based company focused on reinventing how doctors review and report on diagnostic exams to drive productivity, portability, and improved communication and clinical decision making. Hitachi expects that the acquisition of VidiStar will advance the company's informatics strategy and analytics capabilities to improve workflow and intelligence for physicians, particularly with those providers conducting diagnostic ultrasound examinations.
"VidiStar has developed a cloud-based diagnostic viewer and customizable structured reporting solution for medical imaging and clinical decision support. With VidiStar, physicians can interpret exams over the web and deliver improved visualization and timely results with the extended care teams.” said William Burns, Senior VP, Hitachi Healthcare Americas.
“We are very excited about VidiStar becoming part of the Hitachi team and believe this partnership will further our client’s ability to reduce inefficiencies in clinical and operational workflows. We will work together to create the next generation of healthcare informatics and analytics solutions so providers and healthcare professionals can take full advantage of the power of informatics." said Craig Walker, CEO of Vidistar.
“This acquisition will add significant talent and expertise in expanding our Healthcare Informatics business at Hitachi. As the healthcare market transitions from volume to value-based care, structured reporting and advanced analytics will play a critical role in enabling and supporting this transition.” said Yasuhiko Taniguchi, CEO of Hitachi Healthcare Americas.
Structured reporting can help standardize and improve the quality of clinical reports and streamline communication among care teams while reducing errors. Advanced analytics and data mining can help identify key value drivers, improve decision making, and ensure that providers and healthcare professionals are informed and efficient in their mission to deliver high quality care.
Upon completion of the transaction, VidiStar and its employees will become part of the Hitachi Healthcare Americas business group within Hitachi. VidiStar will maintain its current headquarters office in Greenville, SC.
About VidiStar, LLC
VidiStar, LLC is based in Greenville, SC (USA) and has developed a web-based diagnostic viewer and patented structured reporting solution (US Pat. No. 8,200,505) for medical imaging and clinical decision support. VidiStar's technology allows physicians and healthcare providers the ability to read and interpret diagnostic studies over the internet for timely interpretation, improved patient diagnosis, clinical decision support, and advanced patient data analytics and notification. VidiStar is a 2012 and 2013 Innovision Award Winner and a 2008 and 2010 SCLaunch Portfolio Company.
About Hitachi Healthcare Americas Corporation
Hitachi Healthcare Americas Corporation, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi, Ltd. offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.
About Hitachi, Ltd.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at http://www.hitachi.com/.
Sam Patrick posted an articleSCBIO has named its 2018 Board of Directors and Board Chair see more
SCBIO has announced its 2018 Board of Directors and Executive Committee following formal confirmation at the life science organization’s December 2017 meeting in Columbia. Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve as SCBIO’s 2018 Board Chair.
Ms. Kennedy joined Nephron Pharmaceuticals in 2001, and assumed the position of President and CEO in 2007. She has held a variety of marketing and operational roles during her career and has helped Nephron Pharmaceuticals grow by 300% and increased shipped product to one billion doses each of the last seven years. Nephron recently built a state of the art manufacturing facility in West Columbia, South Carolina and, with her husband Bill, helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy.
Joining Ms. Kennedy as officers on the SCBIO Executive Committee will be Craig Walker, CEO of VidiStar LLC as Vice Chair; Michael Rusnak, Executive Director of the Medical University of South Carolina Research Foundation as Treasurer; and Kathryn Cole Becker, Principal of Translational Science Solutions as Secretary. Additional members of the Executive Committee are Jeff Stover, Special Counsel with Haynsworth Sinkler Boyd, PA as Legal Officer; Stephanie Yarbrough, Partner with Womble Bond Dickinson, LLP as Annual Conference Officer; Bryan Davis, Operations Manager with Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; and Sam Konduros, President and CEO of SCBIO. Immediate Past Chair, Erin Ford, who now serves as the organization’s inaugural Vice President, was honored for her extraordinary board service during the December Board meeting.
Also elected to the 22-member Board of Directors for SCBIO are Darralyn Alexander, President of Reimbursement Strategies LLC; Mandy Brawley, Deputy Director of the South Carolina Department of Commerce; Jerry Chang, Vice President of Business Development for BioD; Matthew Couvillion, Attorney with the Wyche Law Form; J.J. Darby, State Government Affairs Leader for Johnson & Johnson Services; Tressa Gardner, Associate Vice president of the Southeastern Institute of Manufacturing and Technology at Florence-Darlington Technical College; and Mike Graney, Vice President for Global Business Development of the Charleston Regional Development Alliance.
Completing the 2018 Board of Directors for SCBIO are Chad Hardaway, Associate Director of the Office of Economic Engagement at the University of South Carolina; Willard Harms, VP of Medical Affairs for Blue Cross Blue Shield of South Carolina; Dr. Martine LaBerge, Chair of Clemson University’s Department of Bioengineering; Marc Metcalf, Business Recruitment Officer of the Upstate SC Alliance; Kathy Phlegar, President of Phlegar & Associates; Christine Dixon Thiesing, Director of Academic Programs for the South Carolina Research Authority; and Courtney Warren, Life Sciences Practice Chair for Marsh & McLennan Agency.
SCBIO President and CEO Konduros praised the Board and Executive Committee noting, “With the important work we are undertaking to actively advance life sciences R&D, biotech, med-tech, and digital health industries in South Carolina, we require strong, expert leadership from all across the state, fully integrating the business, education and economic development sectors. I am confident that these diverse leaders who reside in communities ranging from Murrells Inlet to Florence in addition to Greenville, Columbia, and Charleston, will effectively champion our vision of building the business of life sciences in South Carolina in 2018 and for years to come.”
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry already has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.
The Board of Directors is the policy- and strategy-making body of the organization, and meets regularly to receive updates on SCBIO business and objectives, as well as domestic and global initiatives. The Executive Committee serves roles specific to SCBIO operations, focus areas and strategies.
SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations. SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.